On the other hand, studies of women with gestational diabetes, diabetes mellitus or obesity show that the risk of preeclampsia, caesarean section or preterm birth is lower [14, 15] or similar when the effect of metformin is compared to the placebo or to insulin [15–17, 20]. This evidence concerns the gene INS and obesity disorder.